High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease

This study has been terminated.

( Efforts at recruitment have halted as recruitment was poor. )

Study NCT00417690 Information provided by Jacobus Pharmaceutical

First Received: January 2, 2007 Last Updated: October 14, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	October 2008
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)